ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 86 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $884,652 | +92.9% | 132,433 | +142.3% | 0.00% | – |
| Q2 2023 | $458,497 | -82.9% | 54,648 | -79.7% | 0.00% | -100.0% |
| Q1 2023 | $2,676,433 | +508.6% | 269,530 | +326.6% | 0.00% | – |
| Q4 2022 | $439,747 | -42.7% | 63,182 | -63.4% | 0.00% | – |
| Q1 2022 | $768,000 | -46.3% | 172,798 | -51.6% | 0.00% | – |
| Q4 2021 | $1,430,000 | +80.8% | 357,356 | +296.3% | 0.00% | – |
| Q3 2021 | $791,000 | -4.7% | 90,182 | +23.1% | 0.00% | – |
| Q2 2021 | $830,000 | +113.9% | 73,242 | +124.4% | 0.00% | – |
| Q1 2021 | $388,000 | -29.8% | 32,645 | -59.5% | 0.00% | – |
| Q4 2020 | $553,000 | +325.4% | 80,560 | +360.1% | 0.00% | – |
| Q3 2020 | $130,000 | -76.3% | 17,509 | -86.7% | 0.00% | – |
| Q2 2020 | $549,000 | +594.9% | 131,590 | +1100.5% | 0.00% | – |
| Q3 2017 | $79,000 | – | 10,961 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,031,915 | $20,253,192 | 21.02% |
| Perceptive Advisors | 11,350,085 | $75,818,568 | 2.53% |
| JOHNSON & JOHNSON | 394,834 | $2,637,491 | 0.97% |
| Joseph P. Lucia & Associates, LLC | 28,331 | $189,251 | 0.13% |
| WOODSTOCK CORP | 137,179 | $916,356 | 0.12% |
| Palo Alto Investors LP | 160,800 | $1,074,144 | 0.10% |
| Affinity Asset Advisors, LLC | 44,348 | $296,245 | 0.08% |
| Verition Fund Management LLC | 935,273 | $6,247,624 | 0.07% |
| FOX RUN MANAGEMENT, L.L.C. | 33,519 | $223,907 | 0.07% |
| TOBIAS FINANCIAL ADVISORS, INC. | 34,173 | $228,276 | 0.06% |